Damian Refojo
|
Damian Refojo, MD PhDResearch group leader |
|
| Phone: | 089/30622-240 | |
| Fax: | 089/30622-610 | |
| Email: | refojo[a]mpipsykl.mpg.de | |
| Interests: | CRH, antidepressants, mood disorders, synaptic plasticity, neuronal development | |
| CV: Born in Buenos Aires, Argentina. Medical Doctor at the Faculty of Medical Sciences, University of Buenos Aires. PhD at the Faculty of Biological Sciences, University of Buenos Aires (2005). Postdoctoral studies at the Max Planck Institute of Psychiatry, Munich (2006-2008). Since 2009 Independent Junior Research Group Leader of the “Molecular Neurobiology” group at the Max Planck Institute of Psychiatry. |
||
| Selected publications: Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, Vogl AM, Dedic N, Schumacher M, von Wolff G, Avrabos C, Touma C, Engblom C, Schütz G, Nave K-A, Eder M, Wotjak CT, Sillaber I, Holsboer F, Wurst W, Deussing JM. (2011) Glutamatergic and Dopaminergic Neurons Mediate Anxiogenic and Anxiolytic Effects of CRHR1. Science, in press. Refojo D, Holsboer F. (2009) CRH signaling: molecular specificity for drug targeting in the CNS. Ann N Y Acad Sci, 1179:106-19. Lu A, Steiner MA, Whittle N, Vogl AM, Walser SM, Ableitner M, Refojo D, Ekker M, Rubenstein JL, Stalla GK, Singewald N, Holsboer F, Wotjak C, Wurst W, Deussing JM. (2008) Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol Psychiatry, 13:1028-1042. Refojo D, Echenique C, Müller MB, Reul JMHM, Deussing J, Wurst W, Sillaber I, Paez-Pereda M, Holsboer F, Arzt E. (2005) CRH activates ERK1/2 MAPK in specific brain areas. Proc Natl Acad Sci U S A 102:6183-6188 Paez Pereda M, Giacomini D, Refojo D, Carbia Nagashima A, Hopfner U, Grübler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E. (2003) Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk Proc Natl Acad Sci, 100:1034-1039 |
||


